Literature DB >> 30023969

Surgical approaches for papillary microcarcinomas: Turkey's perspective.

Özer Makay1, Murat Özdemir1, Yasemin Giles Şenyürek1, Fatih Tunca1, Mete Düren1, Mehmet Uludağ1, Mehmet Hacıyanlı1, Gökhan Içöz1, Adnan Işgör1, Serdar Özbaş1, Zehra Özcan1, Serdar Tezelman1.   

Abstract

OBJECTIVES: The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size, has been increasing in the last decade. Herein, we present internet-based questionnaire results performed by the Turkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillary microcarcinomas in Turkey.
MATERIAL AND METHODS: The user-friendly questionnaire consisted of 13 questions in total. These questions mainly addressed the surgical management of nodules and cancer of <1 cm in size. Patient management before, during, and after surgical intervention was also included; additionally, the "active surveillance approach" was questioned.
RESULTS: There were 420 responders in total who were of multidisciplinary origin (endocrinologists, surgeons, nuclear medicine specialists, pathologists, and oncologists). Total thyroidectomy was the predominant treatment approach (65%) for the classical type of microcarcinoma limited in one lobe, whereas in cases of microcarcinomas incidentally diagnosed during hemithyroidectomy, complementary surgery approach was advised by 40% of the responders. The responders found capsule invasion (86%) and patient based management (94%) of high importance. The percentage of the responders who recommended radioactive iodine ablation in incidental cancers having no aggressive criteria was 51%. The survey participants that were against routine central dissection in these cases accounted for 73% of the responders. The recommendation of active surveillance (follow-up without any interventional therapy) was limited with 9% responders.
CONCLUSION: The results of the questionnaire demonstrated that there have been various choices in Turkey for the surgical treatment of the papillary microcarcinomas.

Entities:  

Keywords:  Papillary microcarcinoma; Turkey; thyroidectomy

Year:  2018        PMID: 30023969      PMCID: PMC6048650          DOI: 10.5152/turkjsurg.2018.3596

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  16 in total

Review 1.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.

Authors:  Tae Yong Kim; Won Bae Kim; Yoon Soo Rhee; Ja Young Song; Jung Min Kim; Gyungyub Gong; Seungkoo Lee; Sang Yoon Kim; Seong Chul Kim; Suck Joon Hong; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2006-09       Impact factor: 3.478

4.  Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.

Authors:  Claire Schvartz; Franck Bonnetain; Sandrine Dabakuyo; Mélanie Gauthier; Adèle Cueff; Sandrine Fieffé; Jean-Marie Pochart; Inna Cochet; Elodie Crevisy; Audrey Dalac; Dimitri Papathanassiou; Michel Toubeau
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

6.  Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.

Authors:  Akira Miyauchi; Takumi Kudo; Akihiro Miya; Kaoru Kobayashi; Yasuhiro Ito; Yuuki Takamura; Takuya Higashiyama; Mitsuhiro Fukushima; Minoru Kihara; Hiroyuki Inoue; Chisato Tomoda; Tomonori Yabuta; Hiroo Masuoka
Journal:  Thyroid       Date:  2011-06-07       Impact factor: 6.568

7.  Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.

Authors:  Yasuhiro Ito; Akira Miyauchi; Minoru Kihara; Takuya Higashiyama; Kaoru Kobayashi; Akihiro Miya
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

8.  Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma.

Authors:  Brian R Untch; Frank L Palmer; Ian Ganly; Snehal G Patel; R Michael Tuttle; Jatin P Shah; Ashok A Shaha
Journal:  Ann Surg Oncol       Date:  2013-12-24       Impact factor: 5.344

9.  Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

Authors:  Cristiana Lupi; Riccardo Giannini; Clara Ugolini; Agnese Proietti; Piero Berti; Michele Minuto; Gabriele Materazzi; Rossella Elisei; Massimo Santoro; Paolo Miccoli; Fulvio Basolo
Journal:  J Clin Endocrinol Metab       Date:  2007-09-04       Impact factor: 5.958

10.  Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.

Authors:  Iwao Sugitani; Kazuhisa Toda; Keiko Yamada; Noriko Yamamoto; Motoko Ikenaga; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.